Eli Lilly & Company (LLY) - Financial Dashboard

Income Statement

Net Income: $970.3 M

Revenue Per Share: $1.07

Balance Sheet

Total Cash and Case Eq: $3,369.0 M

Total Current Liabilities: $24,674.3 M

Cash Flow Statement

Cash and Cash Equivalents: $6,344.1 M

Important Terms
Analysis
Key Highlights:
  • Revenue Drivers: Major products contributing to revenue include Mounjaro, Trulicity, Verzenio, Zepbound, Taltz, Jardiance, Humalog, and more.
  • Mounjaro Growth: U.S. revenue grew significantly due to high demand and price increases post $25 non-covered benefit expiration in June 2023.
  • Trulicity and Verzenio: Trulicity faced U.S. revenue decline due to competition; Verzenio saw growth from higher demand and prices.
  • Manufacturing Investments: Expected increase in capital expenditures due to new facilities and supply agreements.
  • Acquisition: Lilly acquired Morphic for $2.67 billion in Q3 2024, funded by debt issuance.
  • Cash Position: Cash increased to $3.37 billion as of September 30, 2024.
  • Share Repurchase: Repurchased $521.1 million under the $5 billion program as of September 30, 2024.
  • Dividends Declared: $3.51 billion in dividends declared as of September 30, 2024.
  • Planned Sales: Dr. Daniel Skovronsky plans to sell up to 5,000 shares in 2025.
  • Risks: Regulatory issues, supply chain dynamics, tax law changes, and more pose risks.
  • Legal Proceedings: Engaged in various legal and environmental proceedings.
  • Effective Tax Rate: The tax rate was 38.9% (Q3) and 19.1% (YTD 2024).
  • Total Debt: Increased to $31.1 billion in 2024.
Disclaimer

This financial analysis is autogenerated and may have significant errors. The analysis is for information purpose only, and is not intended to be personal financial advice. Contact us at hello@lumorill.com for any feedback, question, or concern.

Data access for executive dashboards

A meticulously verified financial dataset can be provided to enhance executive dashboards. Our service facilitates integration with Salesforce Tableau, Microsoft PowerBI, SAP Analytics Cloud, and various other BI platforms. For further information, please reach out to hello@lumorill.com.

About Us

Lumorill empowers businesses with advanced tech solutions in Executive Dashboards, Generative AI, and Talent Management. Our expertise in AI-driven analytics, automation, and strategic talent sourcing boosts efficiency, innovation, and workforce competitiveness across sectors, including Healthcare and Financials. Our commitment to partnering with clients drives industry growth and success.